Natasha Hernday

Natasha Hernday is a declared insider at 2 companies; the most frequent names are XOMA Royalty Corp and Janux Therapeutics, Inc. The record holds 7 filings, for trades running from 15 May 2024 to 14 July 2026.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 14 July 2026, the filings show a transaction in XOMA Royalty Corp. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.